Literature DB >> 15007610

[Incomplete, incongruent homonymous hemianopsia toward the right].

K H Eibl1, A S Neubauer, A Kampik, M W Ulbig.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15007610     DOI: 10.1007/s00347-003-0922-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  7 in total

1.  Acute homonymous field loss: really a diagnostic dilemma.

Authors:  M L Slavin
Journal:  Surv Ophthalmol       Date:  1990 Mar-Apr       Impact factor: 6.048

2.  A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis.

Authors:  Ulf Baumhackl; Claudia Franta; Johann Retzl; Erich Salomonowitz; Gerald Eder
Journal:  Vaccine       Date:  2003-04-01       Impact factor: 3.641

3.  Demyelinative chiamal lesions.

Authors:  R H Spector; J S Glaser; N J Schatz
Journal:  Arch Neurol       Date:  1980-12

4.  Bilateral homonymous visual field defects as initial manifestation of multiple sclerosis.

Authors:  B Sanchez-Dalmau; F J Goñi; M Guarro; C Roig; F Duch-Bordas
Journal:  Br J Ophthalmol       Date:  1991-03       Impact factor: 4.638

5.  Uncommon chiasmal lesions: demyelinating disease, vasculitis, and cobalamin deficiency.

Authors:  H Wilhelm; W Grodd; U Schiefer; E Zrenner
Journal:  Ger J Ophthalmol       Date:  1993-08

Review 6.  Optic neuritis in multiple sclerosis.

Authors:  Jane W Chan
Journal:  Ocul Immunol Inflamm       Date:  2002-09       Impact factor: 3.070

7.  Crossed quadrant homonymous hemianopsia in a case of multiple sclerosis.

Authors:  M Cesareo; C Pozzilli; G Ristori; A M Roscioni; A Missiroli
Journal:  Clin Neurol Neurosurg       Date:  1995-11       Impact factor: 1.876

  7 in total
  1 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.